Semaglutide

glucagon-like-peptide-1 (GLP-1) receptor agonist

What is Semaglutide?

Semaglutide (sold under brand names like Ozempic and Wegovy) is a GLP-1 receptor agonist approved for weight management and type 2 diabetes. It works by reducing appetite, delaying gastric emptying, and promoting a feeling of fullness, helping to lower caloric intake. Clinical studies show it can achieve an average weight loss of up to 15% of body weight when combined with a healthy diet and lifestyle. It also regulates blood sugar by enhancing insulin secretion and suppressing glucagon.